Alerts will be sent to your verified email
Verify EmailBANDARAM
|
Bandaram Pharma Pack
|
ANG Lifesciences
|
Bacil Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.64 % | 12.03 % | 0.32 % |
|
5yr average Equity Multiplier
|
4.09 | 3.3 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
0.98 | 0.77 | 0.0 |
|
5yr Avg Net Profit Margin
|
1.46 % | -2.26 % | 0.0 |
|
Price to Book
|
2.05 | 1.06 | 2.3 |
|
P/E
|
121.67 | 0.0 | 36.69 |
|
5yr Avg Cash Conversion Cycle
|
185.52 Days | 70.26 Days | 0.0 |
|
Inventory Days
|
58.64 Days | 107.37 Days | 0.0 |
|
Days Receivable
|
164.3 Days | 274.82 Days | 0.0 |
|
Days Payable
|
29.07 Days | 235.98 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
2.12 | 1.81 | -943.72 |
|
5yr Avg ROCE
|
8.53 % | 15.08 % | -75.56 % |
|
5yr Avg Operating Profit Margin
|
7.35 % | 7.68 % | 0.0 |
|
5 yr average Debt to Equity
|
2.33 | 0.97 | 0.05 |
|
5yr CAGR Net Profit
|
16.17 % | n/a | n/a |
|
5yr Average Return on Assets
|
1.43 % | 1.04 % | -70.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.66 % | 70.6 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 44.88 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-12.34 % | 0.0 | -42.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bandaram Pharma Pack
|
ANG Lifesciences
|
Bacil Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|